Tuesday, April 19, 2016

BRIEF-J&J says does not expect Remicade to face competition from U.S. biosimilar this year

* Says in conference call that he does not expect Remicade

sales to be hurt by biosimilars this year in United States

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)